Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2017 2
2018 4
2019 4
2020 10
2021 10
2022 8
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3.
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, van de Giessen E, Van Weehaeghe D, Morbelli S. Guedj E, et al. Among authors: van weehaeghe d. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):632-651. doi: 10.1007/s00259-021-05603-w. Epub 2021 Dec 9. Eur J Nucl Med Mol Imaging. 2022. PMID: 34882261 Free PMC article.
FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.
Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H. Verger A, et al. Among authors: van weehaeghe d. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1553-1555. doi: 10.1007/s00259-023-06177-5. Eur J Nucl Med Mol Imaging. 2023. PMID: 36869178 Free PMC article. No abstract available.
Theranostics in Neurooncology: Heading Toward New Horizons.
Tolboom N, Verger A, Albert NL, Fraioli F, Guedj E, Traub-Weidinger T, Morbelli S, Herrmann K, Zucchetta P, Plasschaert SLA, Yakushev I, Weller M, Glas M, Preusser M, Cecchin D, Barthel H, Van Weehaeghe D. Tolboom N, et al. Among authors: van weehaeghe d. J Nucl Med. 2024 Feb 1;65(2):167-173. doi: 10.2967/jnumed.123.266205. J Nucl Med. 2024. PMID: 38071569
EANM position paper: theranostics in brain tumours-the present and the future.
Tolboom N, Verger A, Albert NL, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Herrmann K, Traub-Weidinger T, Morbelli S, Yakushev I, Zucchetta P, Barthel H, Van Weehaeghe D. Tolboom N, et al. Among authors: van weehaeghe d. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):202-205. doi: 10.1007/s00259-023-06425-8. Eur J Nucl Med Mol Imaging. 2023. PMID: 37698647 No abstract available.
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.
De Marchi F, Munitic I, Amedei A, Berry JD, Feldman EL, Aronica E, Nardo G, Van Weehaeghe D, Niccolai E, Prtenjaca N, Sakowski SA, Bendotti C, Mazzini L. De Marchi F, et al. Among authors: van weehaeghe d. Neurosci Biobehav Rev. 2021 Aug;127:958-978. doi: 10.1016/j.neubiorev.2021.06.027. Epub 2021 Jun 19. Neurosci Biobehav Rev. 2021. PMID: 34153344 Free PMC article. Review.
The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee. Garibotto V, et al. Among authors: van weehaeghe d. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y. Eur J Nucl Med Mol Imaging. 2021. PMID: 34272989 No abstract available.
42 results